Choong-wae wins in finasteride patent dispute

Published: 2004-03-19 06:59:00

Updated: 2004-03-19 06:59:00

Choong-wae Pharm won in an injunction trial sought by MSD Korea, which stops Choong-wae from manufacturing Finastartablet (finasteride) for the treatment of benign prostate hyperplasia (BPH), which was launched in the latter half of last year.

MSD Korea has initiated legal action against Choon...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK